Suven Pharmaceuticals enters into settlement with CSIR by admin- Friday, June 11th, 2021 03:48:23 PM
Suven Pharmaceuticals, CSIR-Indian Institute of Chemical Technology, Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have entered into an settlement for the system technology transfer and production of the anti COVID drug, Molnupiravir and a couple of-DG. It
is a associated party transaction as one in every of our Independent Directors Dr S Chandrasekhar is the Director of CSIR-IICT, Hyderabad.
The agreements between the events involve a total fee of Rs. Eight lakh plus taxes for the provide of the licenses on non-different foundation to SPL.
Ipca Lab acquires additional 13.09% stake in Trophic Wellness
Ipca Laboratories has acquired in addition thirteen.09% of the paid-up equity proportion capital of M/s. Trophic Wellness Private Ltd. (TWPL), a business enterprise incorporated underneath the Companies Act, 1956 and engaged within the enterprise of producing and marketing numerous SKUs of Neutraceuticals underthe logo call “Nutricharge”.
With this acquisition of these thirteen.09% of the equity share capital, the said M/s. Trophic Wellness Pvt. Ltd. Has come to be a subsidiary of the Company. The Company now holds fifty two.35% of the paid-up fairness share capital of TWPL.